| Literature DB >> 30618463 |
Paula Braitstein1, David Ayuku2, Allison DeLong3, Dominic Makori4, Edwin Sang4, Carren Tarus4, Allan Kamanda5, Pooja Shah4, Edith Apondi5, Juddy Wachira2.
Abstract
OBJECTIVE: To obtain an estimate of the size of, and human immunodeficiency (HIV) prevalence among, young people and children living on the streets of Eldoret, Kenya.Entities:
Mesh:
Year: 2018 PMID: 30618463 PMCID: PMC6307507 DOI: 10.2471/BLT.18.210211
Source DB: PubMed Journal: Bull World Health Organ ISSN: 0042-9686 Impact factor: 13.831
Sociodemographic characteristics of the sampled young people and children living on the streets in Eldoret, Kenya, September 2016
| Covariate | No. (%) | |||
|---|---|---|---|---|
| Total ( | Children aged < 15 years ( | Youths aged 15–24 years ( | Adults aged 25–29 years ( | |
| Male | 1049 (73.9) | 321 (64.6) | 511 (78.3) | 217 (80.7) |
| Female | 370 (26.1) | 176 (35.4) | 142 (21.7) | 52 (19.3) |
| Home with parents or legal guardian | 284 (20.0) | 237 (47.7) | 39 (6.0) | 8 (3.0) |
| Home with sibling or other relative | 142 (10.0) | 33 (6.6) | 64 (9.8) | 45 (16.7) |
| Rental with friends | 210 (14.8) | 33 (6.6) | 139 (21.3) | 38 (14.1) |
| Streets (sidewalks, market, veranda) | 291 (20.5) | 79 (15.9) | 155 (23.7) | 57 (21.2) |
| Barracks | 160 (11.3) | 33 (6.6) | 92 (14.1) | 35 (13.0) |
| Other (specified) | 332 (23.4) | 82 (16.5) | 164 (25.1) | 86 (32.0) |
| Yes | 1027 (72.4) | 372 (74.8) | 465 (71.2) | 190 (70.6) |
| No | 390 (27.5) | 123 (24.7) | 188 (28.8) | 79 (29.4) |
| Missing | 2 (0.1) | 2 (0.4) | 0 (0.0) | 0 (0.0) |
HIV: human immunodeficiency virus.
a Median age (interquartile range) of total, children, youths and adults: 18 (12–23), 9 (3–13), 19 (17–22) and 27 (26–28) years.
Note: Inconsistencies arise in some values due to rounding.
Fig. 1Age and sex distribution of counted young people and children living on the streets, Eldoret, Kenya, September 2016
HIV testing and counselling outcomes of young people and children living on the streets in Eldoret, Kenya, September 2016
| Covariate | No. (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Total | Children aged < 15 years | Youths aged 15–24 years | Adults aged 25–29 years | |||||
| Males ( | Females ( | Males ( | Females ( | Males ( | Females ( | Males ( | Females ( | |
| Yes | 734 (98.0) | 270 (96.4) | 230 (95.0) | 122 (93.1) | 374 (99.2) | 105 (99.1) | 130 (100.0) | 43 (100.0) |
| No | 15 (2.0) | 10 (3.6) | 12 (5.0) | 9 (6.9) | 3 (0.8) | 1 (0.9) | 0 (0.0) | 0 (0.0) |
| Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Known positive | 5 (0.7) | 14 (5.0) | 0 (0.0) | 0 (0.0) | 2 (0.5) | 5 (4.7) | 3 (2.3) | 9 (20.9) |
| Not known or negativea | 743 (99.2) | 265 (94.6) | 242 (100.0) | 131 (100.0) | 375 (99.5) | 100 (94.3) | 126 (96.9) | 34 (79.1) |
| Missing | 1 (0.1) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.9) | 1 (0.8) | 0 (0.0) |
| Yes | 3 (60.0) | 13 (92.9) | NA | NA | 1 (50.0) | 5 (100.0) | 2 (66.7) | 8 (88.9) |
| No | 2 (40.0) | 1 (7.1) | NA | NA | 1 (50.0) | 0 (0.0) | 1 (33.3) | 1 (11.1) |
| Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Yes | 700 (94.1) | 247 (92.9) | 215 (88.8) | 116 (88.5) | 363 (96.8) | 99 (98.0) | 122 (96.1) | 32 (94.1) |
| No | 44 (5.9) | 19 (7.1) | 27 (11.2) | 15 (11.5) | 12 (3.2) | 2 (2.0) | 5 (4.0) | 2 (5.9) |
| Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Positive | 14 (2.0) | 9 (3.6) | 2 (0.9) | 1 (0.9) | 8 (2.2) | 6 (6.1) | 4 (3.3) | 2 (6.3) |
| Negative | 679 (97.0) | 236 (95.5) | 211 (98.1) | 115 (99.1) | 350 (96.4) | 91 (91.9) | 118 (96.7) | 30 (93.8) |
| Indeterminate | 3 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (0.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Missing | 4 (0.6) | 2 (0.8) | 2 (0.9) | 0 (0.0) | 2 (0.6) | 2 (2.0) | 0 (0.0) | 0 (0.0) |
| 19 (2.7) | 23 (8.9) | 2 (0.9) | 1 (0.9) | 10 (2.8) | 11 (10.8) | 7 (5.6) | 11 (26.8) | |
HIV: human immunodeficiency virus; NA: not applicable.
a These numbers included those known to be HIV negative, those who had never been tested and those who may have tested negative many months previously and felt they had recently been exposed.
b These numbers include 10 participants who had declined HIV counselling.
c Including previously known and newly tested positive individuals, excluding indeterminate results and missing data.
Note: Inconsistencies arise in some values due to rounding.
Difference in uptake of HIV testing and HIV seroprevalence of young people and children living on the streets, Eldoret, Kenya, September 2016
| Covariate | OR (95% CI) | |
|---|---|---|
| Agreed to HIV testa | HIV seroprevalenceb | |
| Male | 1.00 | 1.00 |
| Female | 1.02 (0.58–1.80) | 4.38 (2.30–8.34) |
| < 15 years | 1.00 | 1.00 |
| 15–24 years | 4.20 (2.24–7.85) | 6.65 (1.95–22.74) |
| 25–29 years | 2.80 (1.22–6.39) | 16.81 (4.80–58.8 7) |
| < 15 years | ||
| Male | NA | 1.00 |
| Female | NA | 0.92 (0.08–10.23) |
| 15–24 years | ||
| Male | NA | 1.00 |
| Female | NA | 4.23 (1.74–10.27) |
| 25–29 years | ||
| Male | NA | 1.00 |
| Female | NA | 6.18 (2.21–17.29) |
CI: confidence interval; HIV: human immunodeficiency virus; NA: not applicable; OR: odds ratio.
a Excluding those already known to be HIV-positive.
b A combination of those already known to be HIV positive plus those who tested positive during this study, excluding indeterminate results and missing data.
Note: For the uptake of HIV testing, sex and age categories are adjustment variables.
Fig. 2HIV seroprevalence of young people and children living on the streets, Eldoret, Kenya, September 2016